home All News open_in_new Full Article

Ahead of Hong Kong IPO, China drug maker Hengrui touts partnership with US giant Merck

China’s Hengrui Pharmaceuticals seeks a path to growth as its pipeline of novel drugs expands.


today 6 h. ago attach_file Events



ID: 3752361402
Add Watch Country

arrow_drop_down